Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Taisho Pharmaceutical R&D Inc.
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy adult male and female participants between 18 and 55 years of age
Body weight greater than or equal to 45 kg
Body Mass Index (BMI) greater than or equal to 18 and less than or equal to 30 kg/m\^2
You may not be if
Female participants who are pregnant, intend to become pregnant, or are breastfeeding
Clinically significant abnormal physical examination, 12-lead electrocardiogram (ECG) OR cardiac telemetry prior to dosing.
Significant history or presence of hepatic, renal, cardiovascular, pulmonary, gastrointestinal, hematological, locomotor, immunologic, ophthalmologic, metabolic or oncological disease.
History or presence of psychiatric or neurologic disease or condition
History of alcohol or drug abuse
Any participant who currently uses or has used tobacco or tobacco-containing products for at least one month prior to screening
Participated in strenuous exercise within 48 hours prior to study start (initial dosing) and/or are unwilling to avoid strenuous exercise at any time throughout the study.
